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EXTRAORDINARY CASE REPORT
Cutaneous Borreliosis With a T-Cell–Rich Infiltrate and
Simultaneous Involvement by B-Cell Chronic Lymphocytic
Leukemia With t(14;18)(q32;q21)
Werner Kempf, MD,* Dmitry V. Kazakov, MD, PhD,*† Eugen Hübscher, MD,‡
and Marianne Tinguely, MD*
Abstract: Pseudolymphomatous inﬁltrates in Borrelia infection of
the skin most commonly manifest with dense B-cell inﬁltrates and
plasma cells. Cutaneous inﬁltrates of B-cell chronic lymphocytic leu-
kemia (B-CLL) may accumulate at sites of infection, including Borrelia
infection. We report an unusual constellation in a patient with synchro-
nously diagnosed B-CLL and Borrelia infection of skin presenting with
a dense dermal T-cell–rich inﬁltrate masking speciﬁc leukemic inﬁl-
trates of neoplastic B cells in the context of B-CLL harboring t(14;18)
(q32;q21). Speciﬁc cutaneous involvement by B-CLL was conﬁrmed
by the detection of t(14;18)(q32;q21) (BCL2–IGH) using FISH in neo-
plastic B cells within the skin inﬁltrates. Borrelia burgdorferi (sensu
lato) DNA detected by nested polymerase chain reaction in the skin
biopsy and serological ﬁndings proved Borrelia infection. Complete
resolution of the cutaneous inﬁltrates was observed after antibiotic
treatment. This case demonstrates that Borrelia infection of the skin
may present with dense T-cell–rich inﬁltrates mimicking cutaneous
T-cell lymphoma and masking the synchronous presence of neoplastic
B cells in the context of B-CLL.
Key Words: cutaneous lymphoma, leukemia, borreliosis, t(14;18),
BCL-2, pseudolymphoma
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INTRODUCTION
B-cell chronic lymphocytic leukemia (B-CLL) is one of
the most common form of leukemias. Speciﬁc cutaneous
inﬁltrates of B-CLL are found in about 25% of patients.1 The
onset of skin lesions has been suggested in some cases to be
triggered by antigenic stimulation. In line with this proposition is
the occurrence of speciﬁc skin inﬁltrates at the sites of herpes
simplex, herpes zoster, chicken pox, and Borrelia burgdorferi
infection.2–5 In 2 previously published articles focused on the
association of cutaneous involvement by B-CLL and B. burg-
dorferi infection, the inﬁltrate of B-cells dominated the histopath-
ological picture and was readily recognizable by the
predominance of B cells having typical immunophenotype.6,7
We present an extraordinary case of B-CLL involving the skin,
in which the neoplastic population comprised only a minority of
the inﬁltrate and was masked by a predominantly T-cell inﬁltrate
as a result of underlying Borrelia infection.
CASE REPORT
A 72-year-old man presented with a solitary skin lesion on his
left side of his chest wall that had been present for 3 months
according to the patient. His complaint also included fatigue. Apart
from the fatigue and skin lesion, the medical history was unremark-
able. Clinical examination revealed a 7-cm annular plaque with
accentuated and more inﬁltrated margins and a clear central portion
showing ﬁne scaling (Fig. 1A). The initial laboratory investigation
revealed an elevated peripheral blood lymphocyte count (53.21 ·
106/mL; the norm: 1.5–4.0); the differential diagnosis included spe-
ciﬁc cutaneous involvement by CLL or cutaneous T-cell lymphoma,
such as unilesional mycosis fungoides (MF). However, because of
the solitary presentation, which would be unusual for B-CLL, and
the patient living in an endemic area for borreliosis and resemblance
of the skin lesion with erythema migrans, borreliosis was considered
as a further differential diagnosis. Subsequent serological studies
revealed elevated titers of both immunoglobulin (Ig) M and IgG
for B. burgdorferi. The patient was investigated simultaneously to
clarify the nature of the skin lesion and underwent a workup for his
peripheral blood leukocytosis at a hemato-oncology department.
Fluorescence-activated cell sorting analysis of the peripheral blood
yielded a predominant B-cell population, with 95% B cells express-
ing the following phenotype: CD19+, CD20 weakly+, sIgM weakly+,
CD5+, CD23+, CD222, CD79a2, and CD382. A bone marrow aspi-
rate revealed an increased number of lymphocytes (48%, the norm
3%–17%). A diffuse involvement by small B cells (up to 50%) of the
bone marrow was evident in a bone marrow biopsy. A t(14;18)(q32;
q21) (BCL2–IGH) was detected by FISH in the bone marrow spec-
imen. Computer tomography investigation revealed mild splenomeg-
aly (14 cm) and slightly enlarged retroperitoneal, axillary, and
inguinal lymph nodes (up to 2.2 cm).
After diagnosis of cutaneous borreliosis was rendered rudocy-
cline (100 mg bid for 2 weeks) was administered, which resulted in
complete remission of the skin lesion (Fig. 1B). No treatment for
B-CLL was initiated because the patient was asymptomatic. No relapse
of the skin lesion was observed during a follow-up period of 12 months.
CUTANEOUS HISTOPATHOLOGICAL AND
IMMUNOHISTOCHEMICAL FINDINGS
A skin biopsy demonstrated a dense band-like lym-
phoid inﬁltrate in the upper dermis and perivascular inﬁltrates
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in the mid dermis composed predominantly of small lym-
phocytes with chromatin dense nuclei but in addition
admixture of a few medium-sized lymphocytes with slightly
atypical nuclei (Figs. 2A, B). Only a few plasma cells were
present. There were foci with minimal exocytosis of lympho-
cytes and subtle vacuolization at the junctional zone, but
largely, the epidermis was uninvolved. A few interstitial his-
tiocytes and mild ﬁbrosis in the papillary dermis were found.
Immunohistochemically, the T-cell population comprised
about 90% of the inﬁltrate and mostly consisted of small and
medium-sized lymphocytes co-expressing CD3 and CD4,
whereas about 10% of the inﬁltrate represented CD20- and
CD79a-positive B cells (Figs. 3A, B). Most T cells also
expressed CD5 and CD7. Staining for CD138 showed the pres-
ence of only a few plasma cells. A small number of lymphocytes
which accounted for less than 5% of the entire inﬁltrate, ex-
pressed CD5 and CD23 (Fig. 3C). There was no expression of
CD30 or cytotoxic proteins, such as T-cell intracellular antigen-1.
MOLECULAR BIOLOGICAL AND
CYTOGENETIC FINDINGS
Multiplex polymerase chain reaction using BIOMED
2 primers for T-cell receptor gene rearrangement revealed
a polyclonal pattern. Nested polymerase chain reaction for
B. burgdorferi (sensu lato)–speciﬁc DNA sequences proved
positive in the skin biopsy.
Interphase FISH analysis for BCL2 break-apart
probe (Abbott Molecular) was performed according to the
manufacturer’s instruction, accustomed to the need of our
tissue. Brieﬂy, deparafﬁnization and pretreatment of a 3-mm
section were followed by 9 minutes incubation in Pronase E
(0.05%) (VWR, Dietikon, Switzerland). Denaturation at 738C
and overnight hybridization at 378C were performed
(HyBrite, Abbott Molecular). One hundred nuclei were eval-
uated at a Zeiss Axio Imager.Z2. Images were acquired with
a Z stack using ZEN 2012 software (Carl Zeiss AG, Feldbach,
Switzerland). Twenty-six out of 100 nuclei (26%) showed
a split signal, indicating a break in the BCL2 gene and hence
a translocation at 18q21 (cutoff: 3% assessed as mean and
3-fold SD) (Fig. 4).
DISCUSSION
We report on an unusual case of borreliosis mimicking
T-cell lymphoma because of the presence of atypically
appearing T cells and the presence of neoplastic B cells of
concurrently diagnosed B-CLL. Speciﬁc cutaneous involve-
ment by B-CLL has a plethora of clinicopathological mani-
festations.1,8 The commonest presentation is with multiple
patches.9–12 An unusual but well-documented presentation is
the occurrence of speciﬁc B-CLL inﬁltrates in the vicinity of
epithelial and nonepithelial lesions, including squamous cell
carcinoma, keratoacanthoma, melanoma, Merkel cell carci-
noma, dermatoﬁbroma to name but a few.13–18 Additionally,
an association of B-CLL and various cutaneous T-cell lympho-
mas has been documented, including MF, Sézary syndrome,
peripheral T-cell lymphoma involving the skin, and natural
FIGURE 1. An annular plaque on the
left side of the chest with accentu-
ated and more infiltrated margins
and a clear central portion showing
fine scaling before treatment (A).
Complete remission of the skin
lesion followed by administration of
rudocycline (B).
FIGURE 2. A dense band-like lym-
phoid infiltrate in the upper dermis
and perivascular infiltrates in the mid
dermis (A) [hematoxylin and eosin
(H&E), original magnification, ·10].
Close-up: small lymphocytes with
chromatin dense nuclei admixed
with few medium-sized lymphocytes
with slightly atypical nuclei (B)
(H&E, original magnification, ·400).
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killer–cell lymphoma.19–21 Occurrence of leukemic inﬁltrates
on the site of a previous herpes simplex or herpes zoster infec-
tion leads to the speculation that speciﬁc skin inﬁltrates of
B-CLL can be triggered by antigenic stimulation.2–5,22 We
are aware of 2 previously published articles documenting the
association of speciﬁc B-CLL inﬁltrates and B. burgdorferi
infection. In 2002, Cerroni et al6 reported 6 patients with spe-
ciﬁc cutaneous involvement of B-CLL at the sites typical for
B. burgdorferi–induced pseudolymphoma, namely, the nipple
and scrotum. Remarkably, the lesions were solitary, thus mak-
ing separation from Borrelia-induced benign lymphoid hyper-
plasia difﬁcult. Parenthetically, pseudolymphoma at the above
sites has been shown to manifest some atypical histopatholog-
ical features, including an Indian ﬁle pattern simulating speciﬁc
cutaneous involvement by B-CLL.23,24 In 2011, Kash et al7
reported a 69-year-old woman with speciﬁc cutaneous inﬁltrate
of B-CLL occurring at the site of erythema chronicum migrans
due to of B. burgdorferi infection. In all the above cases, in-
ﬁltrates of B-CLL were readily identiﬁable based on their
monotonous inﬁltrates and their immunophenotype. In con-
trast, in our patient, the neoplastic B cells of B-CLL were
few and masked by a predominantly T-cell inﬁltrate, which
is another unusual ﬁnding.
Pseudolymphomatous inﬁltrates in Borrelia infection of
the skin most commonly manifest with dense B-cell inﬁltrates
with admixture of plasma cells. Furthermore, cases of low-grade
malignant cutaneous B-cell lymphomas, such as plasma cell–
rich variant of cutaneous marginal zone lymphoma (formerly
referred to as cutaneous immunocytoma), have been found in
Borrelia infection. Exception to these B-cell–predominant
dense lymphocytic inﬁltrates in Borrelia infection, erythema
migrans, is a T-cell–dominated process.25 Apart from the latter
work, Tee et al26 described 11 patients with acrodermatitis
chronica atrophicans, of which 8 cases showed a band-like
T-cell–predominant lymphocytic inﬁltrate, exocytosis of lym-
phocytes, and a ﬁbrotic papillary dermis resembling features in
MF. In addition, we recently described a case of B. burgdorferi–
associated lobular panniculitis resembling subcutaneous panni-
culitis–like T-cell lymphoma typiﬁed by a T-cell inﬁltrate with
cytotoxic phenotype.27 These observations and the presented
case demonstrate that cutaneous Borrelia infection is occasion-
ally associated with T-cell–rich inﬁltrates mimicking various
forms of cutaneous T-cell lymphomas or secondary cutaneous
inﬁltrates of T-cell neoplasms, such as prolymphocytic T-cell
leukemia/lymphoma.
In addition to the T-cell–predominant component of the
inﬁltrates in our patient, B cells were found, including a few
CD5 and CD23+ B cells. FISH analysis demonstrated that
these cells in the skin carried the very same t(14;18)(q32;
q21) translocation as identiﬁed in the neoplastic cells of
B-CLL in the bone marrow and peripheral blood. This
FIGURE 3. Staining for CD3 (A), CD20 (B), and CD23 (C) demonstrates that the majority of the infiltrate consists of CD3-positive
T cells with only very few CD20-positive B cells and admixture of a few scattered B cells (immunohistochemistry, alkaline
phosphatase-anti-alkaline phosphatase). Note also focal exocytosis with lining up of lymphocytes within the basal cell layer.
FIGURE 4. FISH break-apart probe of the BCL-2 gene showing
many reactive infiltrating cells with a normal genotype for
BCL-2 as indicated by 2 fused yellow (green and red) fusion
signals on each chromosome (asterix). A few cells show a clear
split of 1 green and 1 red signal (arrow) on 1 chromosome,
indicating a translocation at this gene locus. We interpret this
as scarce infiltrate of circulating B-CLL cells demonstrating
a translocation t(14;18) of the IGH and BCL-2 genes in this
patient.
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translocation is a cytogenetic hallmark of extracutaneous fol-
licular lymphoma and can also be found in a subset of nodal
diffuse large B-cell lymphomas. In addition, occasional cases
of CLL/small lymphocytic lymphoma with t(14;18) have
been reported.28,29 In our case, the break in the BCL2 gene
detected in a portion of the cellular inﬁltrate is compatible
with the presence of the same clone of B-CLL cells with
a translocation t(14;18)(q32;q21) as previously detected in
the bone marrow of this patient. This is interesting because
morphologically and by immunohistochemistry, the B-CLL
inﬁltrate was below the detection limit. Taken together, we
face here the unusual constellation of a T-cell–driven immune
reaction to B. burgdorferi admixed with malignant B-CLL
cells carrying a translocation involving the BCL2 gene. This
also stresses the usefulness of FISH in biopsies with B-CLL,
in which leukemic inﬁltrates are not readily apparent on
hematoxylin and eosin–stained sections. In analogy, Mittel-
dorf et al30 documented a patient with B-CLL manifesting
histologically an insect bite–like reaction, in which interphase
FISH performed on the skin biopsy revealed a deletion of
TP53 previously found in the peripheral blood of the patient.
Recently, Tang et al31 indicated that the t(14;18) in CLL was
associated with relatively young age at diagnosis, mutated Ig
heavy chain variable region genes, and a more aggressive
clinical course usually requiring chemotherapy. In contrast,
B-CLL in our patient exhibited an indolent course.
In conclusion, we have described an extraordinary case
with speciﬁc cutaneous involvement by B-CLL with t(14;18)
(q32;q21) translocation that presented in the skin with a minor
neoplastic cell population masqueraded by a predominant
T-cell inﬁltrate associated with B. burgdorferi infection.
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